About this sample
This is a second illustrative sample, using bioequivalence CROs as the example category. As with all sample reports on this site, figures and findings are illustrative and intended to demonstrate methodology, not to represent a specific client's live results.
Why this category is instructive
Bioequivalence studies are a highly specialised research category, and buyers evaluating CRO partners typically ask AI tools narrow, technical questions — for example, about therapeutic area experience, regulatory submission track record, or site capacity. Narrow categories like this one show clearly how much AI responses depend on whether an organisation has made its specific experience explicit and easy to interpret.
Illustrative finding pattern
In our demonstration sampling, AI tools frequently answered narrow bioequivalence prompts with general CRO names rather than specialists, unless a specialist organisation had made its therapeutic area experience, study volume, and regulatory track record unambiguous across public sources. This illustrates why generic company descriptions tend to under-perform in AI discovery, even when the underlying expertise is strong.
What the full report includes
A completed report for a CRO client documents exactly which prompts surface the organisation today, which do not, why, and the specific content and structural changes required to close the gap — followed by execution.